Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Renal Cancer Clinical Oncology

  • Manfred Johannsen
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_6329-2

Definition

Renal cell carcinoma is a cancer arising from the epithelial cells of the kidney. It must be distinguished from transitional cell carcinoma of the renal pelvis.

Characteristics

Clinical Epidemiology

Renal cancer accounts for 2–3 % of all adult malignancies and is the third most frequent urological malignancy after prostate cancer and bladder cancer. The incidence of renal cancer has been increasing during the last 30 years from approximately 7/100,000 to 11/100,000 in 2002 (Decastro et al. 2008). This rise is primarily due to the fact that renal masses are increasingly being diagnosed incidentally by routine imaging studies. Worldwide, the mortality from renal cancer exceeds 100,000 per year (Eble et al. 2004). Renal tumors occur more commonly in men than woman, the male/female ratio for renal cancer being about 2/1. Approximately one-third of patients present with metastatic disease at the time of diagnosis. Additionally, 30 % of all other patients develop metastasesat a...

Keywords

Vascular Endothelial Growth Factor Renal Tumor Partial Nephrectomy Renal Cancer Radical Nephrectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. Bex A, Larkin J, Voss M (2015) Challenging the treatment paradigm for advanced renal cell carcinoma: a review of systemic and localized therapies. Am Soc Clin Oncol Educ Book e239–47. doi: 10.14694/EdBook_AM.2015.35.e239Google Scholar
  2. Decastro GJ, McKiernan JM (2008) Epidemiology, clinical staging and presentation of renal cell carcinoma. Urol Clin North Am 35(4):581–592CrossRefPubMedGoogle Scholar
  3. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) Tumours of the urinary system and male genital organs. World Health Organisation classification of tumours. IARC Press, LyonGoogle Scholar
  4. Hollingsworth JM, Miller DC, Daignault S et al (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98:1331–1334CrossRefPubMedGoogle Scholar
  5. Johannsen M, Brinkmann OA, Bergmann L et al (2007) The role of cytokine therapy in metastatic renal cell cancer. Eur Urol Suppl 6:658–664CrossRefGoogle Scholar
  6. Kroog GS, Motzer RJ (2008) Systemic therapy for metastatic renal cell carcinoma. Urol Clin North Am 35(4):687–701CrossRefPubMedGoogle Scholar
  7. Ljundberg B, Bensalah K, Canfield S et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924Google Scholar
  8. Linehan WM, Yang JC, Bates SE (2004) Cancer of the kidney. In: DeVita SE, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 7th edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  9. Ljundberg B, Hanbury DC, Kuczyk M et al (2007) Renal cell carcinoma guideline. Eur Urol 51:1502–1510CrossRefGoogle Scholar
  10. Störkel S, Kristiansen G, Moch H (2007) The importance of pathology and genetics for the diagnosis and therapy of renal cell carcinoma. Eur Urol Suppl 6:603–610CrossRefGoogle Scholar

See Also

  1. (2012) Autosomal Dominant. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 323. doi:10.1007/978-3-642-16483-5_489Google Scholar
  2. (2012) Axitinib. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 324. doi:10.1007/978-3-642-16483-5_6701Google Scholar
  3. (2012) Computed Tomography. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 964–965. doi:10.1007/978-3-642-16483-5_1295Google Scholar
  4. (2012) Cryoablation. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1001. doi:10.1007/978-3-642-16483-5_6503Google Scholar
  5. (2012) Cytotoxic Chemotherapy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1058. doi:10.1007/978-3-642-16483-5_1499Google Scholar
  6. (2012) Interleukin-2. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1892. doi:10.1007/978-3-642-16483-5_3097Google Scholar
  7. (2012) Laparoscopy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1979. doi:10.1007/978-3-642-16483-5_3276Google Scholar
  8. (2012) Monoclonal Antibody Therapy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 2367–2368. doi:10.1007/978-3-642-16483-5_3823Google Scholar
  9. (2012) MTOR. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2384. doi:10.1007/978-3-642-16483-5_3867Google Scholar
  10. (2012) Normoxia. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2557. doi:10.1007/978-3-642-16483-5_4129Google Scholar
  11. (2012) Obesity. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2595. doi:10.1007/978-3-642-16483-5_4185Google Scholar
  12. (2012) Paraneoplastic Syndromes. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 2784–2785. doi:10.1007/978-3-642-16483-5_4387Google Scholar
  13. (2012) Pazopanib. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2799. doi:10.1007/978-3-642-16483-5_6694Google Scholar
  14. (2012) Renal Oncocytoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3252. doi:10.1007/978-3-642-16483-5_6507Google Scholar
  15. (2012) Radiofrequency Ablation. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3148. doi:10.1007/978-3-642-16483-5_6490Google Scholar
  16. (2012) Retroperitoneoscopic. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3292. doi:10.1007/978-3-642-16483-5_6502Google Scholar
  17. (2012) Smoking. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3455. doi:10.1007/978-3-642-16483-5_5382Google Scholar
  18. (2012) Sunitinib. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3562. doi:10.1007/978-3-642-16483-5_5575Google Scholar
  19. (2012) Transforming Growth Factor Alpha. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3758. doi:10.1007/978-3-642-16483-5_5915Google Scholar
  20. (2012) Tumor Suppressor. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3803. doi:10.1007/978-3-642-16483-5_6056Google Scholar
  21. (2012) Tyrosine Kinase. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3822. doi:10.1007/978-3-642-16483-5_6079Google Scholar
  22. (2012) Ultrasound. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3836. doi:10.1007/978-3-642-16483-5_6097Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Facharztpraxis Urologie Johannsen & LauxBerlinGermany